1Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A new assay reliably quantifies gene dosage for Charcot-Marie-Tooth disease type 1A (CMT1A) by normalizing Southern blot signals. This method accurately determines if patients have one, two, or three copies of the duplicated region, aiding diagnosis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: